Zhi Xie
- Molecular Biology top 1%
- Oncology top 1%
- Pulmonary and Respiratory Medicine top 1%
- Cancer Research top 1%
- Plant Science top 2%
- Topics
- Gut microbiota and health (43 papers)Lung Cancer Treatments and Mutations (38 papers)RNA modifications and cancer (23 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Zhi Xie
360 papers receiving 10.5k citations
Hit Papers
Peers
Comparison fields: 5 of 188
- Molecular Biology 5.3k
- Oncology 2.5k
- Pulmonary and Respiratory Medicine 2.1k
- Cancer Research 1.2k
- Plant Science 879
Countries citing papers authored by Zhi Xie
This map shows the geographic impact of Zhi Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhi Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhi Xie more than expected).
Fields of papers citing papers by Zhi Xie
This network shows the impact of papers produced by Zhi Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhi Xie. The network helps show where Zhi Xie may publish in the future.
Co-authorship network of co-authors of Zhi Xie
This figure shows the co-authorship network connecting the top 25 collaborators of Zhi Xie. A scholar is included among the top collaborators of Zhi Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhi Xie. Zhi Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 2 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 3 | |
| 7 | 0 | |
| 8 | 3 | |
| 9 | 6 | |
| 10 | 7 | |
| 11 | 8 | |
| 12 | 3 | |
| 13 | 16 | |
| 14 | 1 | |
| 15 | 47 | |
| 16 | 23 | |
| 17 | 8 | |
| 18 | 1 | |
| 19 | Potential Predictive Value of TP53 and KRAS Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinomabreakdown → | 741 |
| 20 | 135 |
About Zhi Xie
Zhi Xie is a scholar working on Pharmacology, Molecular Biology and Oncology, having authored 376 papers that have together received 10.6k indexed citations. Recurring topics across this work include Gut microbiota and health (43 papers), Lung Cancer Treatments and Mutations (38 papers) and RNA modifications and cancer (23 papers). The work is most often cited by research in Oncology (2.5k citations), Cancer Research (1.2k citations) and Molecular Biology (5.3k citations). Zhi Xie has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yi‐Long Wu, Xu‐Chao Zhang, Qing Zhou, Jian Su, Wen‐Zhao Zhong, Qiongfeng Liao, Jin‐Ji Yang, Qiongfeng Liao, Hai‐Yan Tu and Zhong‐Yi Dong. Their work appears in journals such as Cell, Nucleic Acids Research and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.